These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21479428)

  • 41. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer.
    Wang Y; Kuramitsu Y; Tokuda K; Baron B; Kitagawa T; Akada J; Maehara S; Maehara Y; Nakamura K
    PLoS One; 2014; 9(10):e109076. PubMed ID: 25271986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.
    Li M; Yu X; Guo H; Sun L; Wang A; Liu Q; Wang X; Li J
    Tumour Biol; 2014 Mar; 35(3):2461-71. PubMed ID: 24218335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges.
    Pan S; Brentnall TA; Kelly K; Chen R
    Proteomics; 2013 Feb; 13(3-4):710-21. PubMed ID: 23125171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
    Boreddy SR; Pramanik KC; Srivastava SK
    Clin Cancer Res; 2011 Apr; 17(7):1784-95. PubMed ID: 21350002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Yoshida K; Kuramitsu Y; Murakami K; Ryozawa S; Taba K; Kaino S; Zhang X; Sakaida I; Nakamura K
    Anticancer Res; 2011 Jun; 31(6):2103-8. PubMed ID: 21737628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry.
    Mikuriya K; Kuramitsu Y; Ryozawa S; Fujimoto M; Mori S; Oka M; Hamano K; Okita K; Sakaida I; Nakamura K
    Int J Oncol; 2007 Apr; 30(4):849-55. PubMed ID: 17332923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Taba K; Fujimoto M; Okita K; Nakamura K; Sakaida I
    Mol Med Rep; 2008; 1(3):429-34. PubMed ID: 21479428
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.